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Abstract
Objective: The aim of this study was to investigate whether foot and lower limb related symptoms were
associated with work participation and poor mobility in people with Systemic Lupus Erythematosus (SLE).
Method: A quantitative, cross-sectional, self-reported survey design was utilised. People with SLE from six United
Kingdom (UK) treatment centres and a national register were invited to complete a survey about lower limb and
foot health, work participation and mobility. Data collected included work status and the prevalence of foot
symptoms. The focus of the analyses was to explore potential associations between poor foot health work non-
participation.
Results: In total, 182 useable surveys were returned. Seventy-nine respondents reported themselves as employed
and 32 reported work non-participation. The remaining were retired due to age or reported work non-participation
for other reasons. Work non-participation due to foot symptoms was significantly associated with difficulty walking
(p = 0.024), past episodes of foot swelling (p = 0.041), and past episodes of foot ulceration (p = 0.018). There was a
significant increase in foot disability scores amongst those not working (mean 18.13, 95% CI: 14.85–21.41) compared
to those employed (mean 10.16, 95% CI: 8.11–12.21).
Conclusions: Twenty-nine% of people with SLE reported work non-participation because of lower limb or foot
problems. Our results suggest that foot health and mobility may be important contributors to a persons’ ability to
remain in work and should be considered as part of a clinical assessment.
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Introduction
Employment is a key measure of self-worth, as it grants
independence and social esteem. Non-participation in
work is associated with poorer health, higher rates of con-
sultation in primary care and higher rates of indebtedness
and mortality [1]. Musculoskeletal disorders are one of the
two biggest causes of long-term work absenteeism in the
developed world [2]. Inflammatory rheumatic disorders in
particular have been shown to be associated with high
levels of work disability such that 20–70% of people with
rheumatoid arthritis have become work disabled within
5–10 years of symptom onset [3].
Baker and Pope systematically reviewed the published
studies of work disability specifically in people with sys-
temic lupus erythematosus (SLE) in 2009 [4] reporting rates
of work non-participation in 32.5%. However, the reviewers
commented on a heterogeneous literature, measuring work
non-participation in a wide range of different ways, and
highlighted a need for more high-quality research in this
area in order to adequately determine the prevalence and
causes of work non-participation in people with SLE.
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A recent study by Cherry et al [5] has demonstrated
that lower limb and foot problems are highly prevalent
among people with SLE. Previous work has also shown
that these symptoms are associated with substantial
morbidity and functional impairment [5–9]; sixt-one% of
people reported that foot pain adversely affected their
lives [5]. However, to our knowledge, no research to date
has specifically investigated the prevalence of, and rela-
tionship between, lower limb or foot related complica-
tions, poor mobility and work non-participation in
people with SLE.
Therefore, this study seeks to explore the prevalence
of self-reported work non-participation through SLE and
foot symptoms in a sample of people living with SLE.
The main aim and focus of the analyses was to explore
potential associations between poor foot health and
work non-participation.
Methods
Ethics, consent and permissions
The University of Salford (HSCR14/25) National Re-
search Ethics Committee (14/SC/1009) granted ethical
approval for the study. All research was completed in ac-
cordance with the declaration of Helsinki guidelines for
research practice. Information about the purpose and
intended use of the survey was included in a covering
letter as part of the survey data sheet. Consent to take
part in the survey was considered implicit following the
completion and return of the form. Consent to publish
was included.
Study design
A quantitative, cross-sectional, self-reported survey
design was utilised. This work was part of a larger
national survey study, the methods and findings of
which have been reported previously [10]. The current
study aim was pre-specified as an intended sub-analysis
of this larger survey. Data were collected regarding lower
limb and foot health, foot pain, mobility and working
status.
Participants
Participants were included if they had a consultant con-
firmed diagnosis of SLE. The survey was distributed to
all eligible people with SLE attending six UK NHS
Rheumatology departments, where potential participants
were being reviewed in dedicated specialist clinics
(Blackburn, Christchurch, Leeds, Manchester, Salford
and Southampton) and to members of the Lupus UK
membership register via their newsletter.
Outcome measures
The survey also included the Manchester Foot Pain and
Disability Index (MFPDI) [11]. The MFPDI starts with
the stem ‘Because of pain in my feet...’ followed by nine-
teen statements. Responders can select from three
answers; ‘none of the time’ coded 0, ‘on some days’ coded
1, and ‘on most/every day’ coded 2. The last two items
are tautological to the purposes of this study as they
enquire about the impact of foot pain on work and leis-
ure activities and were excluded from the current ana-
lyses. As suggested by Garrow and colleagues [11], the
remaining 17 statements were summated into a simple
score to give a total between 0 and 34, with higher
scores indicative of more severe limitation. Moreover,
we analysed the data using the three constructs of the
MFPDI: mobility; scored between 0 and 20; pain; scored
between 0 and 10 and personal appearance; scored
between 0 and 4.
Our principal outcome measure was work non-partici-
pation (people who reported that they were currently on
long-term sick leave or retired because of SLE or foot
symptoms). Our reference population were respondents
who reported that they were in either paid or voluntary
employment.
Analysis
Initial analyses were descriptive using IBM SPSS Statis-
tics for Windows, Version 21.0 (Armonk, NY: IBM
Corp.) The MFPDI total score and sub-domains were re-
ported as means, accompanied by 95% two-sided confi-
dence intervals. Tests for continuous variables were
carried out as appropriate to their distributions (t-test
for parametric and Mann-Whitney for non-parametric
data). Chi-squared tests were carried out between groups
for the survey responses at the 5% significance level.
Data were analysed using logistic regression with odds
of being in work as opposed to reporting work
non-participation being the dichotomous outcome vari-
able, with both univariable and multivariable associa-
tions modelled.
Results
One hundred and eighty-two people with SLE completed
the questionnaire. Seventy-one of those 182 (39%)
respondents were excluded as they were in neither a
paid/ voluntary job nor long-term sick/retired due to
SLE or foot problems. Statistical comparison of this
group (n = 71) with the remaining 111 respondents for
age in categories (in work most frequent age category =
4 (older); not in work most frequent age category 3; p <
0.001), duration of disease (in work mean duration 13 ±
9 (1–36) years; not in work mean duration 16 ± 10
(18–81) years; p = 0.596), and BMI (in work mean BMI
27 ± 5 (16–44); not in work mean BMI 28 ± 8 (18–42); p
= 0.679), suggested that clinically the excluded partici-
pants were not significantly different but that they were
older. This was not unexpected, given that these
Stevens et al. Journal of Foot and Ankle Research           (2019) 12:26 Page 2 of 5
respondents are most likely retired due to age, not for a
health reason.
Having excluded the 71, the remaining 111 respon-
dents were eligible for further analyses of working status.
Seventy-nine (71%) respondents reported that they were
currently in paid or voluntary employment as compared
with 32 (29%) respondents who reported work
non-participation due to SLE and foot symptoms.
Comparison between those currently working and
those currently reporting work non-participation showed
no differences for ethnicity (p = 0.515) or BMI (p =
0.817) in univariate analyses, as shown in Table 1. Those
who reported work non-participation were more likely
to have a longer disease duration (p = 0.008) and there
was a statistically significant effect of age between the
groups (p = 0.048). When adjusted for age using multi-
variable logistic regression, duration of disease no longer
remained a statistically significant factor (p = 0.132).
A comparison of people currently working with those
reporting work non-participation is shown in Table 2.
All foot symptoms were more frequently reported
amongst those reporting work non-participation than
those currently employed. After adjustment for age,
those not in work were statistically significantly more
likely to report previous foot ulceration (OR 3.47, 95%
CI: 1.24–9.76, p = 0.018) difficulty walking (OR 3.15,
95% CI: 1.16–8.56, p = 0.024) and swelling of the foot/
ankle (OR 2.91, 95% CI: 1.03–8.13, p = 0.041).
Overall, people those reporting work non-participation
had higher mean MFPDI scores (18.13, 95% CI: 14.85–
21.41) than those currently employed (10.16, 95% CI:
8.11–12.21) indicating more severe foot problems.
Moreover, the same was found for each of the three
MFPDI constructs (1. mobility, 2. pain, 3. personal
appearance). After adjustment for age using a multivari-
ate logistic regression model (Table 2) the MFPDI scores
remained statistically significantly different across all
constructs.
Discussion
This study found that 29% of people with SLE eligible to
work report work non-participation because of SLE and
lower limb or foot problems. Moreover, comparison to
those who are currently working with those who are not
shows a greater number of a range of foot problems and
significantly higher MFPDI scores. The only demo-
graphic factor associated with work non-participation
within this dataset was age. However, work non-partici-
pation was associated with: ever having foot ulceration;
swelling of the foot/ankle; and poor mobility/difficulty
walking, even after adjustment for age.
Our finding that work non-participation affects at least
29% of those eligible to work is consistent with the re-
sults from other studies of people with SLE [4, 12–14].
Demographic risk factors for work non-participation
that have been identified by other researchers include
age, ethnicity, lower educational attainment, lower social
class, and disease-specific risk factors include disease
duration, activity, pain, fatigue, depression, cognitive
function, neuropsychiatric manifestations and damage
[15]. To our knowledge however, no other study has
explored the impact of foot symptoms on work partici-
pation and in particular, it would appear that poor
mobility may have an important effect on work partici-
pation. As with other studies, our data are
cross-sectional so that we are unable to draw conclu-
sions about causation. However, it is of interest that high
MFPDI scores and foot ulceration or swelling of the
foot/ankle were significantly associated with risk of work
non-participation and we suggest that future research
about work participation in people with SLE should con-
sider poor mobility and foot symptoms as well as other
factors in prospective studies.
It is of interest that the MFPDI scores amongst those
participating in work still suggest that foot symptoms
are prevalent even when people are sustaining their
work. This of course has important implications
Table 1 A comparison of demographic characteristics between
those in work and those reporting work non-participation
Respondent
characteristic
Number of respondents in
work with symptom
present (n)
(max group size = 79)
Number of
respondents
not in work
with symptom
present (n)
(max group
size = 32)
Statistical
difference
between
groups
Age range 0.001
18–29 8 3
30–39 15 1
40–49 29 8
50–59 24 10
60–69 2 7
70+ 0 2
Ethnicity 0.515
White 63 22
Black 3 3
Asian 6 2
Other 4 3
BMI 0.817
Underweight 1 0
Optimal 35 11
Overweight 16 5
Obese 20 10
Current
smoker
11 4 1.000
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clinically, particularly if it can be demonstrated that
baseline scores predict future work non-participation,
which may allow for targeted personalised care planning.
It suggests that foot health should receive greater em-
phasis within the clinic and that rheumatology clinicians
should regularly ask about foot symptoms and examine
the foot or involve podiatrists in the support of people
with SLE.
It should be borne in mind that there were a number
of limitations to this study. In particular, the numbers of
participants eligible to work who reported work
non-participation was relatively small and the study may
have consequently been relatively under-powered. In
light of that, it is in fact striking that statistically signifi-
cant associations were identified for those reporting
work non-participation. Moreover, because of the rela-
tive rarity of SLE as a condition, this is a large cohort
when compared to the available literature on SLE and
work participation. Another difficulty inherent in the
design of this study was that no information is available
as to the number of non-responders or their clinical
characteristics or work participation. Consequently, we
are unable to conjecture about the size or nature of any
responder bias. It is possible that people with SLE who
perceived themselves as having particular problems with
their foot health were more motivated to participate
than those unaffected by such symptoms. This study was
designed to collect a minimum of personal information
to reduce the burden upon respondents; however this
does mean that there is limited information regarding
disease severity or clinical manifestations that do not
affect the feet. In contrast, a particular strength of this
study is the clarity over the case definition of work par-
ticipation that has been used. Baker and Pope [4] found
this to be a very heterogeneous literature with wide
variation in the types of case definition that had been
used and it is important that research going forwards is
consistent in choosing measureable and reliable
measures of work participation.
Conclusion
To our knowledge this is the first study to examine the
impact of foot symptoms on work amongst people with
SLE. Twenty-nine% of people with SLE eligible to work
reported work non-participation because of SLE and
lower limb or foot problems. Our results suggest that
foot health and poor mobility may be important contrib-
utors to a persons’ ability to remain in work although
further prospective research is recommended. This work
has important implications clinically, particularly if it
Table 2 A comparison of the prevalence of foot symptoms and MFPDI scores in relation to work
In work N = 79 Reporting work non-participation N = 32 OR (95% CI) P-value
N Reported % of employed N Reported % of LTS/ Retired
Raynaud’s in past 42 53.8% 19 59.4% 1.25 (0.54–2.89) 0.265
Calf pain in past 44 55.7% 22 68.8% 1.75 (0.73–4.17) 0.107
Calf night pain in past 59 74.7% 27 87.1% 2.29 (0.71–7.34) 0.065
Loss of feeling in past 10 12.8% 11 34.4% 3.56 (1.33–9.55 0.053
Ulcer in past 16 20.5% 14 43.8% 3.01 (1.24–7.33) 0.018
Hard skin in past 56 72.7% 27 84.4% 2.03 (0.69–5.99) 0.165
Ingrown toenail in past 30 38.0% 16 51.6% 1.74 (0.75–4.03) 0.264
Reported Rash/Blisters 26 32.9% 13 41.9% 1.47 (0.63–3.46) 0.699
Difficulty walking in past 25 31.6% 18 58.1% 2.99 (1.27–7.04) 0.024
Swelling in past 37 46.8% 22 71.0% 2.78 (1.14–6.78) 0.041
Stiffness in past 62 79.5% 28 93.3% 3.61 (0.78–16.79) 0.063
Joint pain in past 64 82.1% 28 93.3% 3.06 (0.65–14.38) 0.155
Change in Foot shape in past 26 33.8% 12 42.9% 1.47 (0.61–3.57) 0.710
MFPDI function score
MAX 20
Mean 6.44 12.10 < 0.001
MFPDI pain score
MAX 10
Mean 3.05 4.52 0.018
MFPDI foot appearance score
MAX 4
Mean 0.72 1.57 0.038
MFPDI Total
MAX 34
Mean 10.16 18.13 < 0.001
Results shown in table two include those adjusted for age
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can be demonstrated that baseline scores predict future
work non-participation, which may allow for targeted
personalised care planning. It suggests that foot health
should receive greater emphasis and that clinicians
should examine and discuss the impact of poor foot
health or involve podiatrists in the support of people
with SLE.
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